Toward a new generation of autonomous implants
The French startup Cairdac is developing ALPS™, an implantable pacemaker that incorporates patented technology to harvest the heart’s kinetic energy to power the device.
This concept paves the way for a new generation of pacemakers that are more self-sufficient and durable.
The device, which is implanted endoscopically, is currently undergoing preclinical testing, with promising results in terms of biocompatibility and performance.
THE TECHNOLOGICAL CHALLENGE
The development of a miniaturized active implant poses significant integration challenges.
The electronic, mechanical, and power components must be integrated into a very small space while ensuring reliability, hermetic sealing, and biocompatibility.
The transition to industrialization also requires the development of robust and reproducible manufacturing processes.
OUR SUPPORT
The development of a miniaturized active implant poses significant integration challenges.
The electronic, mechanical, and power components must be integrated into a very small space while ensuring reliability, hermetic sealing, and biocompatibility.
The transition to industrialization also requires the development of robust and reproducible manufacturing processes.
THE RESULTS
Specialized tools and proven processes have been developed to ensure the precision, repeatability, and quality of the assemblies.
This approach aims to ensure a smooth transition to industrial-scale production and to establish the conditions for reliable, controlled mass production, while meeting the regulatory and economic requirements associated with active implants.
Production of batches for V&V (verification and validation)
Production of batches for First-in-Human (FIH) trials
Are you working on an implant or medical device project?
Let’s discuss your industrial challenges.
